AMN Healthcare's shares rose approximately 19% following the release of an investor slide deck at the J.P. Morgan Healthcare Conference, reflecting strong market confidence in its growth potential.
The company aims for a 50-100 basis point increase in adjusted EBITDA and gross margins by 2026, based on a normalized Q4 revenue run rate, indicating a positive outlook for future profitability. AMN projects a 10%-15% CAGR in adjusted EBITDA post-2026, alongside 4%-6% annual organic revenue growth, which will provide stable cash flow and investment returns for the company.
Management has set a capital expenditure projection of $40M-$45M for 2025, which will support the company's long-term growth strategy and enhance its competitive position in the market.
Wall Street analysts forecast AMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMN is 21.50 USD with a low forecast of 20.50 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast AMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMN is 21.50 USD with a low forecast of 20.50 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
3 Hold
1 Sell
Moderate Buy
Current: 20.190
Low
20.50
Averages
21.50
High
22.00
Current: 20.190
Low
20.50
Averages
21.50
High
22.00
Citizens
Outperform
maintain
$24 -> $22
2025-12-19
Reason
Citizens
Price Target
$24 -> $22
AI Analysis
2025-12-19
maintain
Outperform
Reason
Citizens lowered the firm's price target on AMN Healthcare to $22 from $24 and keeps an Outperform rating on the shares. The firm's December Staffing Trends report updates provider contract labor spending, JOLTS data, nurse wage and exam trends, and reviews 2025 sector M&A activity, the analyst tells investors in a research note. While near-term conditions may remain uneven, the longer-term outlook for healthcare staffing is constructive, with potential for secular stabilization in 2026, the firm adds.
UBS
Neutral
maintain
$18
2025-11-07
Reason
UBS
Price Target
$18
2025-11-07
maintain
Neutral
Reason
UBS raised the firm's price target on AMN Healthcare to $20.50 from $18 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AMN
Unlock Now
Citizens JMP
Outperform
maintain
$22 -> $24
2025-11-07
Reason
Citizens JMP
Price Target
$22 -> $24
2025-11-07
maintain
Outperform
Reason
Citizens JMP raised the firm's price target on AMN Healthcare to $24 from $22 and keeps an Outperform rating on the shares. Management noted that travel nurse demand has steadily increased 50% from the mid-May lows, and remains slightly down year over year, while Allied demand is now flat y/y, the analyst tells investors in a research note. Although staffing gross margin has been under pressure, management believes this dynamic will stabilize as the industry returns to growth, with a rebound in the international nurse business serving as an additional margin tailwind, the firm says.
BofA
Underperform
downgrade
$20 -> $18
2025-09-10
Reason
BofA
Price Target
$20 -> $18
2025-09-10
downgrade
Underperform
Reason
BofA lowered the firm's price target on AMN Healthcare to $18 from $20 and keeps an Underperform rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
About AMN
AMN Healthcare Services, Inc. is a provider of total talent solutions for healthcare organizations across the United States. The Company provides access to a comprehensive network of quality healthcare professionals through its recruitment strategies and breadth of career opportunities. Its segments include nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. The nurse and allied solutions segment includes its travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing businesses. The physician and leadership solutions segment includes its locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company’s language services, vendor management systems (VMS), workforce optimization, and outsourced solutions businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
